AXS-12 (Reboxetine)
AXS-12-201
Phase 3 small_molecule completed
Quick answer
AXS-12 (Reboxetine) for Narcolepsy is a Phase 3 program (small_molecule) at Axsome Therapeutics with 3 ClinicalTrials.gov record(s).
Program details
- Company
- Axsome Therapeutics
- Indication
- Narcolepsy
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed